Enterra Insights
DECEMBER 1, 2022
”[5] Nestlé’s goal is to ensure at least 20% of its key ingredients are sourced through regenerative agricultural methods by 2025 and 50% of its key ingredients are sourced through regenerative agricultural methods by 2030. ” Among the “right” tools, he claims are artificial intelligence and biotech.
NC State SCRC
SEPTEMBER 27, 2023
I had the opportunity to have him talk to my MBA class recently, and we covered a variety of topics – from career development to the biotech industry. Number 1 : I was and remain naturally curious – about the industry, emerging trends and sources of value. I work in biotech, where much of what we do can fail!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Supply Chain View from the Field
AUGUST 8, 2013
Although strategic sourcing capabilities are well established in industries ranging from automotive to electronics, they are still in the formative stages in the biotechnology sector. It isn’t easy to drive change in biotech companies for a number of reasons. is showing how this can happen in the biotech sector.
QAD
JANUARY 19, 2023
E-commerce brands must oversee design, manufacturing, sourcing, warehouse inventory, shipping and delivery. Supply chain management is typically broken into three large buckets of intricate processes and roles: Concept: the full cycle, from sourcing and procurement to fulfillment.
Supply Chain Matters
FEBRUARY 24, 2022
based makers of semiconductors, biotech and biomedical products as well as renewable and energy storage companies to augment manufacturing. Investing in sustainable domestic production and processing of critical minerals in order to decrease dependence on foreign or single sources of supply. Supply Chain Matters Perspectives.
Resilinc
OCTOBER 12, 2021
Geopolitical conflict with Australia—source of 10% of China’s coal imports—have contributed to the coal shortage. Its firms are critical suppliers for pharma/biotech, consumer electronics, automotive, energy, apparel and many other industries; they draw on a huge skilled workforce and have access to unmatched logistics infrastructure.
QAD
JANUARY 27, 2021
Pre-commercial life science manufacturers, including medical device manufacturers, biotech companies, and contract manufacturing organizations (CMOs), face infrastructure challenges as they work toward Food and Drug Administration (FDA) approval.
Expert insights. Personalized for you.
231 
Let's personalize your content